94 related articles for article (PubMed ID: 3146142)
1. Plasminogen activators in the intestine of patients with inflammatory bowel disease.
de Bruin PA; Crama-Bohbouth G; Verspaget HW; Verheijen JH; Dooijewaard G; Weterman IT; Lamers CB
Thromb Haemost; 1988 Oct; 60(2):262-6. PubMed ID: 3146142
[TBL] [Abstract][Full Text] [Related]
2. Urokinase-type plasminogen activator in endothelial cells during acute inflammation of the appendix.
Grøndahl-Hansen J; Kirkeby LT; Ralfkiaer E; Kristensen P; Lund LR; Danø K
Am J Pathol; 1989 Oct; 135(4):631-6. PubMed ID: 2508479
[TBL] [Abstract][Full Text] [Related]
3. Crohn's disease but not chronic ulcerative colitis induces the expression of PAI-1 in enteric neurons.
Laerum OD; Illemann M; Skarstein A; Helgeland L; Ovrebø K; Danø K; Nielsen BS
Am J Gastroenterol; 2008 Sep; 103(9):2350-8. PubMed ID: 18844621
[TBL] [Abstract][Full Text] [Related]
4. Plasminogen activators and tumor development in the human colon: activity levels in normal mucosa, adenomatous polyps, and adenocarcinomas.
de Bruin PA; Griffioen G; Verspaget HW; Verheijen JH; Lamers CB
Cancer Res; 1987 Sep; 47(17):4654-7. PubMed ID: 3621160
[TBL] [Abstract][Full Text] [Related]
5. Plasminogen activators in human nasal polyps and mucosa.
Larsen K; de Maat MP; Jespersen J
Rhinology; 1997 Dec; 35(4):175-7. PubMed ID: 9532638
[TBL] [Abstract][Full Text] [Related]
6. DDAVP induces systemic release of urokinase-type plasminogen activator.
Levi M; ten Cate JW; Dooijewaard G; Sturk A; Brommer EJ; Agnelli G
Thromb Haemost; 1989 Sep; 62(2):686-9. PubMed ID: 2510348
[TBL] [Abstract][Full Text] [Related]
7. [Impaired fibrinolytic response to the venous occlusion test in patients with cryptogenic colitis].
Gris JC; Schved JF; Raffanel C; Dubois A; Ribard D; Balmes JL
Gastroenterol Clin Biol; 1991; 15(12):933-8. PubMed ID: 1783249
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activator profiles in neoplastic tissues of the human colon.
de Bruin PA; Griffioen G; Verspaget HW; Verheijen JH; Dooijewaard G; van den Ingh HF; Lamers CB
Cancer Res; 1988 Aug; 48(16):4520-4. PubMed ID: 3260815
[TBL] [Abstract][Full Text] [Related]
9. Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer.
Ganesh S; Sier CF; Griffioen G; Vloedgraven HJ; de Boer A; Welvaart K; van de Velde CJ; van Krieken JH; Verheijen JH; Lamers CB
Cancer Res; 1994 Aug; 54(15):4065-71. PubMed ID: 8033138
[TBL] [Abstract][Full Text] [Related]
10. Sensitive and specific enzyme-linked immunosorbent assay for urokinase-type plasminogen activator and its application to plasma from patients with breast cancer.
Grøndahl-Hansen J; Agerlin N; Munkholm-Larsen P; Bach F; Nielsen LS; Dombernowsky P; Danø K
J Lab Clin Med; 1988 Jan; 111(1):42-51. PubMed ID: 3121772
[TBL] [Abstract][Full Text] [Related]
11. Fibrinolytic activity and localization of plasminogen activator in bovine vitreous body and aqueous humor.
Hayashi K; Nakashima Y; Sueishi K; Tanaka K
Jpn J Ophthalmol; 1989; 33(1):66-75. PubMed ID: 2499726
[TBL] [Abstract][Full Text] [Related]
12. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
Rość D; Kremplewska-Nalezyta E; Gadomska G; Zastawna E; Michalski A; Drewniak W
Med Sci Monit; 2000; 6(4):684-91. PubMed ID: 11208392
[TBL] [Abstract][Full Text] [Related]
13. Expression of plasminogen activators and plasminogen activator inhibitor 1 in dedifferentiated chondrosarcoma.
Häckel C; Czerniak B; Ayala AG; Radig K; Roessner A
Cancer; 1997 Jan; 79(1):53-8. PubMed ID: 8988726
[TBL] [Abstract][Full Text] [Related]
14. Expression of urokinase-type plasminogen activator (u-PA), u-PA receptor, and tissue-type PA messenger RNAs in human hepatocellular carcinoma.
De Petro G; Tavian D; Copeta A; Portolani N; Giulini SM; Barlati S
Cancer Res; 1998 May; 58(10):2234-9. PubMed ID: 9605771
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of urokinase-type plasminogen activator (PA), PA inhibitor type-1, and tissue-type PA antigen levels in node-negative breast cancer: a prospective study on multicenter basis.
Kim SJ; Shiba E; Kobayashi T; Yayoi E; Furukawa J; Takatsuka Y; Shin E; Koyama H; Inaji H; Takai S
Clin Cancer Res; 1998 Jan; 4(1):177-82. PubMed ID: 9516968
[TBL] [Abstract][Full Text] [Related]
16. Ethanol-induced up-regulation of the urokinase receptor in cultured human endothelial cells.
Tabengwa EM; Grenett HE; Benza RL; Abou-Agag LH; Tresnak JK; Wheeler CG; Booyse FM
Alcohol Clin Exp Res; 2001 Feb; 25(2):163-70. PubMed ID: 11236828
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of plasminogen activators in cancers and normal mucosae of human urinary bladder.
Hasui Y; Suzumiya J; Marutsuka K; Sumiyoshi A; Hashida S; Ishikawa E
Cancer Res; 1989 Feb; 49(4):1067-70. PubMed ID: 2492205
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
Griga T; May B; Pfisterer O; Müller KM; Brasch F
Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
[TBL] [Abstract][Full Text] [Related]
19. Effects of castration on plasminogen activator activities and plasminogen activator inhibitor type 1 in the rat ventral prostate.
Wilson MJ; Ludowese C; Sinha AA; Estensen RD
Prostate; 1996 Apr; 28(4):239-50. PubMed ID: 8602400
[TBL] [Abstract][Full Text] [Related]
20. Urokinase-type plasminogen activator in colorectal cancer: relationship with clinicopathological features and patient outcome.
Skelly MM; Troy A; Duffy MJ; Mulcahy HE; Duggan C; Connell TG; O'Donoghue DP; Sheahan K
Clin Cancer Res; 1997 Oct; 3(10):1837-40. PubMed ID: 9815571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
